Oddity double downgraded to Underperform from Buy at BofA

As previously reported, BofA double downgraded Oddity (ODD) to Underperform from Buy with a price target of $10, down from $58, after the company disclosed meaningful challenges in acquiring new users along with its Q4 report. The issue, discovered in late January, led Oddity to give Q1 revenue guidance of down 30% year-over-year and forgo providing full year guidance, notes the analyst, who forecasts revenue to be down 21.5% in 2026 and sees a low likelihood of recovery until at least 2027.